COPIED
3 mins

RESTORING INTIMATE COMFORT

Dr Ioannis Liakas highlights the use of a non-hormonal treatment for vulvo-vaginal atrophy

Vulvo-vaginal atrophy (VVA) is a common yet often underdiagnosed condition affecting many women, particularly during and after menopause. It occurs due to a decline in oestrogen levels, leading to thinning, drying and inflammation of the vaginal walls. Symptoms can include vaginal dryness, irritation, itching and painful intercourse, all of which can significantly impact quality of life and intimate relationships. VVA is especially prevalent in women who are unable to take hormone replacement therapy (HRT), such as those with a history of hormone-sensitive cancers. As awareness grows, there is increasing demand for safe, effective, non-hormonal treatments that can restore comfort and function without the use of systemic hormones.

PATIENT BACKGROUND

Sarah, a 52-year-old breast cancer survivor, presented to the clinic with severe symptoms of VVA, including persistent vaginal dryness, painful intercourse and general genital discomfort. These symptoms developed following chemotherapy and the discontinuation of hormone replacement therapy (HRT), which was contraindicated due to the hormone-sensitive nature of her cancer.

Having been post-menopausal for several years, Sarah’s VVA symptoms were further compounded by the abrupt cessation of HRT. She had previously trialled over-the-counter vaginal moisturisers and lubricants, which provided only temporary and superficial relief. The lack of long-term improvement and the physical pain caused by vulvar vestibulitis had led Sarah to withdraw from sexual activity entirely.

TREATMENT RATIONALE

Given Sarah’s medical history and inability to use hormonal or invasive therapies, the Caress Flow protocol was selected. This treatment combines high-concentration oxygen therapy with low molecular weight hyaluronic acid to hydrate tissues, improve elasticity and stimulate collagen production – all without hormones or invasive procedures.

The gentle design of the device and its minimal risk profile made it an ideal choice for Sarah, particularly as she was not a suitable candidate for vaginal laser or radiofrequency treatments due to pain sensitivity.

TREATMENT PROTOCOL

Sarah underwent six weekly sessions of Caress Flow in line with the manufacturer’s recommendations. The standard protocol was followed closely, although the oxygen delivery was adjusted to suit Sarah’s comfort levels and ensure a pain-free experience. No additional in-clinic therapies were used during this period, but she was advised to continue with high-quality moisturisers and lubricants between sessions to support hydration.

MECHANISM OF ACTION

Caress Flow works by delivering high-concentration oxygen to improve microcirculation and cellular metabolism, while the low molecular weight hyaluronic acid enhances hydration and elasticity. The combination encourages fibroblast activity and collagen synthesis, contributing to stronger, more resilient vaginal tissue.

PATIENT EXPERIENCE AND TOLERANCE

Sarah described the sessions as completely comfortable and free from pain, likening the experience to a “spa for the vagina”. She reported sensations of warmth and relaxation during treatment and observed immediate post-session benefits. No side effects or adverse reactions were reported throughout the course.

RESULTS AND CLINICAL OUTCOMES

By the third session, Sarah began to report noticeable improvements. By the end of the treatment series, she described herself as “almost completely pain-free” and significantly more comfortable during intimate activity.

Clinical assessments showed visible improvement in mucosal hydration, elasticity, and tissue resilience. Patient-reported outcome measures documented these improvements, confirming the efficacy of the treatment.

COMPARATIVE OUTCOMES

In the clinic’s broader experience, Caress Flow has produced results that are at least on par with, and often superior to, other modalities such as Desirial injections, radiofrequency or hormonal therapies– particularly in terms of patient comfort and satisfaction. The non-invasive, hormone-free nature of Caress Flow has consistently led to quicker symptom relief and higher overall patient acceptance.

LONG-TERM IMPACT AND FOLLOW-UP

Several months post-treatment, Sarah continues to experience lasting relief from her symptoms. While no maintenance sessions have yet been necessary, her condition will be reassessed periodically to determine future needs.

In clinical experience, repeated courses of Caress Flow may provide cumulative benefits, supporting long-term vaginal tissue health and sustained improvement in quality of life.

CLINICAL REFLECTIONS

This case underscores the value of Caress Flow as a reliable, well-tolerated and effective solution for managing VVA in patients who are unable to undergo hormone-based treatments. While the treatment is generally safe, it should be avoided or adapted in cases of active vaginal infection or recent pelvic surgery.

Emerging research supports the integration of oxygen and hyaluronic acid therapy in vaginal rejuvenation, affirming Caress Flow’s role as a valuable addition to the clinician’s toolkit.

DR IOANNIS LIAKAS

Dr Ioannis Liakas is the medical director and lead medical practitioner at Vie Aesthetics, which has locations in London, Essex and Germany. Dr Liakas has decades of experience as an NHS Consultant of Internal Medicine and Gerontologist, and he has been an experienced practitioner in aesthetic medicine for more than 14 years. Dr Liakas is a Fellow of the Royal College of Physicians (FRCP), Honorary Senior Lecturer at Queen Mary Medical School, and a Member of the British College of Aesthetic Medicine.

This article appears in July/August 2025

Go to Page View
This article appears in...
July/August 2025
Go to Page View
DEAR READERS
Former editor Anna Dobbie signs off the July/August issue
MEET THE EXPERTS
The Aesthetic Medicine editorial board’s clinical expertise and diverse range of specialities help ensure the magazine meets the needs of the readers. In this issue, we have received guidance from the following members:
HOT OFF THE PRESS
INDUSTRY NEWS
REVERSE TIME AT THE CELLULAR LEVEL
The Power of SkinCeuticals A.G.E. Interrupter Ultra Serum, by Dr Ahmed El-Houssieny
OUT & ABOUT
Highlights from the sector calendar
PRECISION, BURITY AND PERFORMANCE
Whether you're an experienced practitioner or new to the field, you know how critical precision is for delivering patient satisfaction.
PRECISION, PASSION AND PERSPECTIVE
Former editor Anna Dobbie speaks to Dr Jenny Doyle about her illustrious medical career, while also making time for her passions outside of work
RESTORING INTIMATE COMFORT
Dr Ioannis Liakas highlights the use of a non-hormonal treatment for vulvo-vaginal atrophy
CASE STUDY: TREATING SEVERE, CHRONIC ACNE WITH AVICLEAR
Alice Henshaw describes Audrey Johnson’s journey to clear skin
THE PRINCESS AND THE PRP
Regenerative expert, nurse Claudia McGloin answers all your burning questions
TREATMENT OF DELAYED SECOND-DEGREE CHEMICAL BURN
Clinic director Mei Abadiano assesses the effectiveness, safety, and outcomes of professional-grade medical low level light therapy in treating residual symptoms of a second-degree chemical burn
SPOTLIGHT ON… ZINC
Kezia Parkins takes a look at this powerful mineral and how it can be used in skincare
UNDERSTANDING AND TREATING CELLULITE IN TRANSGENDER PATIENTS
Dr Tatiana Mandavia talks through her holistic, inclusive approach
THE HIDDEN AESTHETIC TOLL OF STRESS
Cardiologist Dr Jay Shah considers how blood pressure monitoring can reveal and reverse the impact of stress
LAUNCHING RIGHT
CQC consultant Tracey Jones considers when the right time is to start your CQC application
REGENERATION BEYOND THE SURFACE
Dr Nima Mahmoodi speaks to Aesthetic Medicine about Remedi London’s integrative ethos, why he’s backing exosome technology and how the future of aesthetics lies in treating the skin and the self
BUILDING TRUST
Dr Olha Vorodyukhina talks to former editor Anna Dobbie about her approach to patient-centric communication
5 MINUTES WITH... AMY BIRD
Nurse prescriber and founder of KAST Aesthetics, Amy Bird, discusses her new role as chair of the British Association of Medical Aesthetic Nurses (BAMAN), the importance of precision in the sector and aesthetic trends for this year and beyond
BEYOND THE CONSENT FORM
Expert witness Jen Vittanuova considers what truly informed consent looks like
EMPLOYEE WELLNESS
Liz McKeon looks at why a happy team equals happy patients
KNOW YOUR RIGHTS
Michelle Bruce, associate at Buckles Law, explains how to navigate the job interview process legally and confidently
HIGH-TECH FACIALS: MEDIK8 CRYSTAL RETINAL AGE-DEFYING FACIAL
Deputy editor Kezia Parkins experienced Medik8’s new Crystal Retinal Age-Defying Facial with celebrity facialist Michaella Bolder
STYLAGE HYDROMAX
Lisa Merrigan visits Dr Zunaid Alli for a Vivacy treatment to improve skin elasticity and hydration
PRODUCT NEWS
The latest product launches
STANDING ON THE SHOULDERS OF GIANTS
The Aesthetic Consultant Vanessa Bird explores imitation in aesthetics
WHAT PATIENTS REALLY WANT
Reena Sandhu does a social listening deep dive into modern aesthetic expectations
IN THE MONEY
Could financial wellness be the workplace benefit your business needs?
THE UK REGULATORY PATHWAY FOR MEDICAL DEVICES
Rosanne Joseph-Anthony offers a comprehensive guide
ASK ALEX
“How can I use WhatsApp and Instagram to improve patient retention?”
Looking for back issues?
Browse the Archive >

Previous Article Next Article